Ligand validation:6VAX

OAA: OXALOACETATE ION

OAA is a Ligand Of Interest in 6VAX designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6VAX_OAA_A_702	7%	19%	0.436	0.888	2.17	1.32	3	1	0	0	100%	1
6VAX_OAA_C_703	2%	20%	0.594	0.845	2.18	1.26	3	-	0	0	100%	1
3SFE_OAA_A_701	33%	1%	0.275	0.957	6.85	1.34	4	1	4	0	100%	1
3SFD_OAA_A_701	29%	1%	0.276	0.935	6.72	1.16	5	-	5	0	100%	1
1AL6_OAA_A_702	100%	16%	0.038	0.992	1.18	2.5	-	5	0	0	100%	1
8GR9_OAA_A_508	94%	16%	0.079	0.977	2.15	1.53	4	1	0	0	100%	1
5ZI4_OAA_B_401	92%	19%	0.081	0.971	2.58	0.89	2	-	1	0	100%	1
2IFC_OAA_B_385	89%	12%	0.074	0.951	2.5	1.65	4	2	0	0	100%	1
5UQR_OAA_A_501	83%	4%	0.085	0.942	2.81	2.99	1	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.